Fig. 1

H&E staining and Ki-67 expression by immunohistochemistry in primary cutaneous malignant melanoma (PCMM). The marker (brown) is expressed in the nuclei of PCMM cells. a: less than 1% of positivity and (b): corresponding to H&E staining; c greater than 60% of positivity and (d) corresponding to H&E staining